BusinessMDA OFFERS LIMB-GIRDLE MUSCULAR DYSTROPHY (LGMD) GENETIC TESTING PROGRAM AT NO COST TO FAMILIESBy Nasdaq OMXSep 28, 2017, 3:12 PM UTC
BusinessaTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an Update on Innovative Immunology PipelineBy Nasdaq OMXAug 14, 2017, 8:06 PM UTC